493 related articles for article (PubMed ID: 2401125)
1. Pharmacokinetics of cefepime in subjects with renal insufficiency.
Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of meropenem in subjects with renal insufficiency.
Leroy A; Fillastre JP; Etienne I; Borsa-Lebás F; Humbert G
Eur J Clin Pharmacol; 1992; 42(5):535-8. PubMed ID: 1607000
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Movahhed H; Tenney J; Martin RR
Antimicrob Agents Chemother; 1992 Mar; 36(3):552-7. PubMed ID: 1622165
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefpiramide in healthy volunteers, patients with various degrees of renal dysfunction, and patients on hemodialysis.
Ohkawa M; Tokunaga S; Sugata T; Shimamura M; Okasho A; Hirano S; Matsui H
Chemotherapy; 1989; 35(6):416-22. PubMed ID: 2612231
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
Garrelts JC; Wagner DJ
Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
Barbhaiya RH; Knupp CA; Pfeffer M; Zaccardelli D; Dukes GM; Mattern W; Pittman KA; Hak LJ
Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of cefepime in patients with thermal burn injury.
Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefepime dihydrochloride arginine in subjects with renal impairment.
Cronqvist J; Nilsson-Ehle I; Oqvist B; Norrby SR
Antimicrob Agents Chemother; 1992 Dec; 36(12):2676-80. PubMed ID: 1482136
[TBL] [Abstract][Full Text] [Related]
11. Teicoplanin pharmacokinetics in patients with chronic renal failure.
Bonati M; Traina GL; Villa G; Salvadeo A; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Clin Pharmacokinet; 1987 Apr; 12(4):292-301. PubMed ID: 2954735
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of rilmenidine in patients with chronic renal insufficiency and in hemodialysis patients.
Aparicio M; Dratwa M; el Esper N; Fillastre JP; Levaltier B; Lins R; Meyrier A; Mignon F; Ryckelynck JP; Sennesael J
Am J Cardiol; 1994 Dec; 74(13):43A-50A. PubMed ID: 7998585
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
14. Disposition of the cephalosporin cefepime in normal and renally impaired subjects.
Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Halstenson CE; Opsahl JA; Pittman KA
Drug Metab Dispos; 1991; 19(1):68-73. PubMed ID: 1673424
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefadroxil in normal subjects and in patients with renal insufficiency.
Humbert G; Leroy A; Fillastre JP; Godin M
Chemotherapy; 1979; 25(4):189-95. PubMed ID: 456077
[TBL] [Abstract][Full Text] [Related]
16. Cefepime pharmacokinetics in cystic fibrosis.
Hamelin BA; Moore N; Knupp CA; Ruel M; Vallée F; LeBel M
Pharmacotherapy; 1993; 13(5):465-70. PubMed ID: 8247913
[TBL] [Abstract][Full Text] [Related]
17. A series of pharmacokinetic studies of ceftaroline fosamil in select populations: normal subjects, healthy elderly subjects, and subjects with renal impairment or end-stage renal disease requiring hemodialysis.
Riccobene T; Jakate A; Rank D
J Clin Pharmacol; 2014 Jul; 54(7):742-52. PubMed ID: 24431097
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration.
Allaouchiche B; Breilh D; Jaumain H; Gaillard B; Renard S; Saux MC
Antimicrob Agents Chemother; 1997 Nov; 41(11):2424-7. PubMed ID: 9371344
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefotetan in normal subjects and patients with impaired renal function.
Ohkawa M; Hirano S; Tokunaga S; Motoi I; Shoda R; Ikeda A; Sugata T; Sawaki M; Shimamura M; Okasho A; Kuroda K
Antimicrob Agents Chemother; 1983 Jan; 23(1):31-5. PubMed ID: 6572490
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.
Conil JM; Georges B; Lavit M; Seguin T; Tack I; Samii K; Chabanon G; Houin G; Saivin S
Int J Clin Pharmacol Ther; 2007 Oct; 45(10):529-38. PubMed ID: 17966838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
